MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1615/critrevimmunol.v27.i5.10

Медицинская библиотека · Critical reviews in immunology · 2007

Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.

Yarchoan Robert, Pluda James M, Wyvill Kathleen M, Aleman Karen, Rodriguez-Chavez Isaac R, Tosato Giovanna, Catanzaro Andrew T, Steinberg Seth M, Little Richard F

СтатьяResearch Support, N.I.H., IntramuralОбзорПеревод в очереди

Аннотация

In this article, we review the preliminary evidence for the activity of interleukin-12 (IL-12) against Kaposi's sarcoma (KS) and discuss these results in the context of the biology of IL-12 and KS. IL-12 is a cytokine that enhances type 1 immunity, induces production of interferon gamma (IFN-gamma), and mediates antiangiogenic effects. In addition, it can downregulate a constitutively active G protein coupled receptor that is encoded by Kaposi's sarcoma-associated herpesvirus, the causative agent of KS. These factors suggested that IL-12 might be worth exploring as a potential anti-KS agent. In an initial phase I pilot study, IL-12 was found to have anti-KS activity when used alone in patients with AIDS-associated KS who were on a stable regimen of antiretroviral therapy. In preliminary results from a subsequent study of the combination of IL-12 plus liposomal doxorubicin along with highly active antiretroviral therapy, remissions were obtained in a substantial percentage of patients with advanced AIDS-associated KS. IL-12 has also been found active in patients with certain lymphomas. These results suggest that IL-12 may be worth exploring further as a potential antitumor agent in selected tumors.

Для цитирования: Yarchoan Robert, Pluda James M, Wyvill Kathleen M, Aleman Karen, Rodriguez-Chavez Isaac R, Tosato Giovanna, Catanzaro Andrew T, Steinberg Seth M, Little Richard F. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.. Critical reviews in immunology. 2007. DOI: 10.1615/critrevimmunol.v27.i5.10.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.